Faecal Calprotectin can help differentiate between IBD and irritable bowel syndrome (IBS), which is important because IBD increases the risk of colorectal cancer. This differentiation can guide further diagnostic steps and treatment plans.
In patients with cancer, Faecal Calprotectin levels might be useful in monitoring the response to treatment. A decrease in levels could indicate a reduction in inflammation and possibly a positive response to therapy.
Research is ongoing to determine if elevated Faecal Calprotectin levels can serve as an early warning sign for colorectal cancer. While it’s not a definitive diagnostic tool on its own, it could potentially be used in conjunction with other screening methods.
Chronic inflammation has been linked to the development of various cancers, including colorectal cancer. Faecal Calprotectin levels can indicate the presence of inflammation, which could be a precursor to cancerous changes.